| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |